Literature DB >> 28094871

Divergence of cAMP signalling pathways mediating augmented nucleotide excision repair and pigment induction in melanocytes.

Erin M Wolf Horrell1,2, Stuart G Jarrett3,2, Katharine M Carter2, John A D'Orazio1,3,2,4,5.   

Abstract

Loss-of-function melanocortin 1 receptor (MC1R) polymorphisms are common in UV-sensitive fair-skinned individuals and are associated with blunted cAMP second messenger signalling and higher lifetime risk of melanoma because of diminished ability of melanocytes to cope with UV damage. cAMP signalling positions melanocytes to resist UV injury by upregulating synthesis of UV-blocking eumelanin pigment and by enhancing the repair of UV-induced DNA damage. cAMP enhances melanocyte nucleotide excision repair (NER), the genome maintenance pathway responsible for the removal of mutagenic UV photolesions, through cAMP-activated protein kinase (protein kinase A)-mediated phosphorylation of the ataxia telangiectasia-mutated and Rad3-related (ATR) protein on the S435 residue. We investigated the interdependence of cAMP-mediated melanin upregulation and cAMP-enhanced DNA repair in primary human melanocytes and a melanoma cell line. We observed that the ATR-dependent molecular pathway linking cAMP signalling to the NER pathway is independent of MITF activation. Similarly, cAMP-mediated upregulation of pigment synthesis is independent of ATR, suggesting that the key molecular events driving MC1R-mediated enhancement of genome maintenance (eg PKA-mediated phosphorylation of ATR) and MC1R-induced pigment induction (eg MITF activation) are distinct.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ATR; DNA repair; UV; melanin; melanocortin 1 receptor; microphthalmia

Mesh:

Substances:

Year:  2017        PMID: 28094871      PMCID: PMC5507718          DOI: 10.1111/exd.13291

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  45 in total

1.  Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity.

Authors:  Zalfa A Abdel-Malek; Ana Luisa Kadekaro; Renny J Kavanagh; Aleksandar Todorovic; Leonid N Koikov; Joseph C McNulty; Pilgrim J Jackson; Glenn L Millhauser; Sandy Schwemberger; George Babcock; Carrie Haskell-Luevano; James J Knittel
Journal:  FASEB J       Date:  2006-05-24       Impact factor: 5.191

Review 2.  Participation of the melanocortin-1 receptor in the UV control of pigmentation.

Authors:  I Suzuki; S Im; A Tada; C Scott; C Akcali; M B Davis; G Barsh; V Hearing; Z Abdel-Malek
Journal:  J Investig Dermatol Symp Proc       Date:  1999-09

3.  Central role of p53 in the suntan response and pathologic hyperpigmentation.

Authors:  Rutao Cui; Hans R Widlund; Erez Feige; Jennifer Y Lin; Dara L Wilensky; Viven E Igras; John D'Orazio; Claire Y Fung; Carl F Schanbacher; Scott R Granter; David E Fisher
Journal:  Cell       Date:  2007-03-09       Impact factor: 41.582

4.  alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

Authors:  E R Price; M A Horstmann; A G Wells; K N Weilbaecher; C M Takemoto; M W Landis; D E Fisher
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

Review 5.  Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention.

Authors:  Zalfa A Abdel-Malek; Viki B Swope; Renny J Starner; Leonid Koikov; Pamela Cassidy; Sancy Leachman
Journal:  Arch Biochem Biophys       Date:  2014-07-11       Impact factor: 4.013

6.  Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.

Authors:  C Haskell-Luevano; H Miwa; C Dickinson; V J Hruby; T Yamada; I Gantz
Journal:  Biochem Biophys Res Commun       Date:  1994-11-15       Impact factor: 3.575

7.  Significance of the melanocortin 1 receptor in the DNA damage response of human melanocytes to ultraviolet radiation.

Authors:  Viki Swope; Christina Alexander; Renny Starner; Sandy Schwemberger; George Babcock; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-12       Impact factor: 4.693

8.  Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein.

Authors:  Tae-Hong Kang; Joyce T Reardon; Aziz Sancar
Journal:  Nucleic Acids Res       Date:  2010-12-30       Impact factor: 16.971

9.  Defining the Contribution of MC1R Physiological Ligands to ATR Phosphorylation at Ser435, a Predictor of DNA Repair in Melanocytes.

Authors:  Stuart G Jarrett; Erin M Wolf Horrell; Mary C Boulanger; John A D'Orazio
Journal:  J Invest Dermatol       Date:  2015-07-13       Impact factor: 8.551

10.  Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.

Authors:  Amaya Viros; Berta Sanchez-Laorden; Malin Pedersen; Simon J Furney; Joel Rae; Kate Hogan; Sarah Ejiama; Maria Romina Girotti; Martin Cook; Nathalie Dhomen; Richard Marais
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962

View more
  4 in total

1.  Melanocortin receptor agonists suppress experimental autoimmune uveitis.

Authors:  Tat Fong Ng; Kaleb Dawit; Andrew W Taylor
Journal:  Exp Eye Res       Date:  2022-02-20       Impact factor: 3.770

2.  DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.

Authors:  Anat Ben-Shlomo; Nan Deng; Evelyn Ding; Masaaki Yamamoto; Adam Mamelak; Vera Chesnokova; Artak Labadzhyan; Shlomo Melmed
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.

Authors:  Timothy J Lavelle; Tine Norman Alver; Karen-Marie Heintz; Patrik Wernhoff; Vegard Nygaard; Sigve Nakken; Geir Frode Øy; Sigurd Leinæs Bøe; Alfonso Urbanucci; Eivind Hovig
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

4.  Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.

Authors:  David L Duffy; Gu Zhu; Xin Li; Marianna Sanna; Mark M Iles; Leonie C Jacobs; David M Evans; Seyhan Yazar; Jonathan Beesley; Matthew H Law; Peter Kraft; Alessia Visconti; John C Taylor; Fan Liu; Margaret J Wright; Anjali K Henders; Lisa Bowdler; Dan Glass; M Arfan Ikram; André G Uitterlinden; Pamela A Madden; Andrew C Heath; Elliot C Nelson; Adele C Green; Stephen Chanock; Jennifer H Barrett; Matthew A Brown; Nicholas K Hayward; Stuart MacGregor; Richard A Sturm; Alex W Hewitt; Manfred Kayser; David J Hunter; Julia A Newton Bishop; Timothy D Spector; Grant W Montgomery; David A Mackey; George Davey Smith; Tamar E Nijsten; D Timothy Bishop; Veronique Bataille; Mario Falchi; Jiali Han; Nicholas G Martin
Journal:  Nat Commun       Date:  2018-11-14       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.